Login / Signup

Inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension.

Caio Julio Cesar Dos Santos FernandesTaysa A F da SilvaJose L AlvesCarlos V P JardimRogério de Souza
Published in: Pulmonary circulation (2021)
Triple combination therapy is suggested in current pulmonary arterial hypertension guidelines in case of unsatisfactory treatment with oral double combination therapy. However, there is a lack of evidence concerning some of the drug combinations currently employed. We demonstrate the clinical and hemodynamical benefits of inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension.
Keyphrases
  • pulmonary arterial hypertension
  • combination therapy
  • pulmonary artery
  • pulmonary hypertension
  • cystic fibrosis
  • emergency department